Forward P/S Multiple: Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care - graphic logo of issuer TNDM

Tandem Diabetes Care (TNDM) leads the development of smart pumps featuring Control-IQ AI algorithms. The expected price-to-sales ratio reflects market expectations, where the 1.20 level captures the current valuation. Manufacturing facilities in California ensure the reliability of system supplies. The company's single-product business profile is offset by a steady profit stream generated from the sale of essential consumables for patients.

tandemdiabetes.com - TNDM Market Cap to Projected Revenue (period 07/04/2022 - 11/17/2026)

Summary analytical data breakdowns for Tandem Diabetes Care (TNDM)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:TNDM (Tandem Diabetes)
Product sample of Tandem Corp

Tandem Diabetes Care develops high-tech insulin pumps that provide therapy automation and high patient loyalty. The forward P/S ratio quantifies this value by comparing the market price per share with projected revenue per share. This metric allows for an assessment of the premium paid for future sales and identifies risks of excessive capital concentration. By analyzing the current forward P/S level, an investor can balance growth potential with fundamental caution.

Who Tandem Diabetes Care competes with

Forward P/S Multiple BSX (bostonscientific.com)|EW: Market Cap to Projected Revenue|ResMed - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Corporation|ZBH: Forward P/S Multiple|COO - Market Cap to Expected Sales Ratio|ALGN (Align Corp) - Forward P/S Multiple|Globus Medical Corp (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Holdings, Inc. ATEC|Forward P/S Multiple AORT (artivion.com)|Forward P/S Multiple Enovis Corp ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Inc) - Forward Price-to-Revenue Multiple|IRADIMED CORPORATION - Forward Price to Sales|EMBC (Embecta Health) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AxoGen Inc AXGN|Price-to-Projected Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Projected Price to Revenue|Forward P/S Multiple BVS (bioventus.com)|Forward P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - Forward P/S Multiple|Market Cap to Expected Sales Ratio Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Ophthalmic)|Price-to-Projected Revenue Ratio clearpointneuro.com|Forward Price-to-Revenue Multiple Stereotaxis, Inc. (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical - Price to Expected Revenue Ratio|VANI (Vivani Medical Inc) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue XTNT|NMTC (n1mtc.com) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Modular Medical MODD|Price-to-Projected Revenue Ratio myomo.com (MYO)|Price-to-Projected Revenue Ratio COCH (envoymedical.com)|Price-to-Projected Revenue Ratio Vivos Therapeutics Inc VVOS|enVVeno Medical Corp. - Price-to-Projected Revenue Ratio|SINT: Forward Price-to-Revenue Multiple|TNON (Tenon Medical, Inc.) - Market Cap to Projected Revenue|Lifeward Ltd. (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix (AMIX)|Price-to-Projected Revenue Ratio INVO Fertility|Bone Biologics Corp. (BBLG) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AXNX (Axonics Modulation Technologies)|BIOL (Biolase, Inc.) - Forward Price to Sales|Forward P/S Multiple DYNT (dynatronics.com)|Forward Price to Sales FNA|INVO Bioscience - Forward P/S Multiple